These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22504829)

  • 81. Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting.
    An J; Cheetham TC; Reynolds K; Alemao E; Kawabata H; Liao KP; Solomon DH
    Arthritis Care Res (Hoboken); 2016 May; 68(5):629-37. PubMed ID: 26414069
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent.
    Koo BS; Hong S; Kim YJ; Kim YG; Lee CK; Yoo B
    Korean J Intern Med; 2015 Jan; 30(1):104-9. PubMed ID: 25589842
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial.
    Charles-Schoeman C; Wang X; Lee YY; Shahbazian A; Navarro-Millán I; Yang S; Chen L; Cofield SS; Moreland LW; O'Dell J; Bathon JM; Paulus H; Bridges SL; Curtis JR
    Arthritis Rheumatol; 2016 Mar; 68(3):577-86. PubMed ID: 26606398
    [TBL] [Abstract][Full Text] [Related]  

  • 84. High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein.
    Rodríguez-Carrio J; Alperi-López M; López P; López-Mejías R; Alonso-Castro S; Abal F; Ballina-García FJ; González-Gay MÁ; Suárez A
    J Clin Lipidol; 2017; 11(4):1043-1054.e2. PubMed ID: 28662934
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Use of Low-Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitor Initiation.
    Rymer JA; Mues KE; Monda KL; Bratton EW; Wirtz HS; Okerson T; Overman RA; Brookhart MA; Muntner P; Wang TY
    J Am Heart Assoc; 2020 May; 9(9):e014347. PubMed ID: 32326795
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Baricitinib induces LDL-C and HDL-C increases in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Qiu C; Zhao X; She L; Shi Z; Deng Z; Tan L; Tu X; Jiang S; Tang B
    Lipids Health Dis; 2019 Feb; 18(1):54. PubMed ID: 30777075
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study.
    Akkara Veetil BM; Myasoedova E; Matteson EL; Gabriel SE; Crowson CS
    J Rheumatol; 2013 Jul; 40(7):1082-8. PubMed ID: 23637326
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cardiovascular (CV) Risk after Initiation of Abatacept versus TNF Inhibitors in Rheumatoid Arthritis Patients with and without Baseline CV Disease.
    Jin Y; Kang EH; Brill G; Desai RJ; Kim SC
    J Rheumatol; 2018 Aug; 45(9):1240-1248. PubMed ID: 29764964
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: analysis from the MonitorNet database.
    Scirè CA; Caporali R; Sarzi-Puttini P; Frediani B; Di Franco M; Tincani A; Sinigaglia L; Sfriso P; Tirri R; Bellis E; Delsante G; Porru G; Salaffi F; Giuggioli D; Rossini M; Todoerti M; Bazzichi L; Govoni M; Gerli R; Raschetti R; Minisola G; Montecucco C; Todesco S;
    Clin Exp Rheumatol; 2013; 31(6):857-63. PubMed ID: 23981363
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Safety, and Humoral and Cell-mediated Immune Responses to Herpes Zoster Vaccine in Patients with Rheumatoid Arthritis.
    Koh JH; Lee J; Kim SH; Kwok SK; Ju JH; Park SH
    J Rheumatol; 2018 Apr; 45(4):465-469. PubMed ID: 29419465
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Very large database of lipids: rationale and design.
    Martin SS; Blaha MJ; Toth PP; Joshi PH; McEvoy JW; Ahmed HM; Elshazly MB; Swiger KJ; Michos ED; Kwiterovich PO; Kulkarni KR; Chimera J; Cannon CP; Blumenthal RS; Jones SR
    Clin Cardiol; 2013 Nov; 36(11):641-8. PubMed ID: 24122913
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation.
    Wolfe F; Michaud K
    Arthritis Rheum; 2007 May; 56(5):1433-9. PubMed ID: 17469100
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effectiveness of statins on total cholesterol and cardiovascular disease and all-cause mortality in osteoarthritis and rheumatoid arthritis.
    Sheng X; Murphy MJ; Macdonald TM; Wei L
    J Rheumatol; 2012 Jan; 39(1):32-40. PubMed ID: 22045835
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis.
    Pollono EN; Lopez-Olivo MA; Lopez JA; Suarez-Almazor ME
    Clin Rheumatol; 2010 Sep; 29(9):947-55. PubMed ID: 20383550
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies.
    Amezaga Urruela M; Suarez-Almazor ME
    Curr Rheumatol Rep; 2012 Oct; 14(5):428-37. PubMed ID: 22802154
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The effects of biologic agents on cardiovascular risk factors and atherosclerosis in rheumatoid arthritis patients: a prospective observational study.
    Papamichail GV; Markatseli TE; Georgiadis AN; Xydis VG; Milionis H; Drosos AA; Voulgari PV
    Heart Vessels; 2022 Dec; 37(12):2128-2136. PubMed ID: 35739432
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort.
    Plant D; Prajapati R; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; Barton A
    Arthritis Rheum; 2012 Mar; 64(3):665-70. PubMed ID: 21952740
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement.
    Johnson BK; Goodman SM; Alexiades MM; Figgie MP; Demmer RT; Mandl LA
    J Rheumatol; 2013 May; 40(5):617-23. PubMed ID: 23547213
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis.
    Zhang J; Chen L; Delzell E; Muntner P; Hillegass WB; Safford MM; Millan IY; Crowson CS; Curtis JR
    Ann Rheum Dis; 2014 Jul; 73(7):1301-8. PubMed ID: 24796336
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effect of JAK inhibitors on high- and low-density lipoprotein in patients with rheumatoid arthritis: a systematic review and network meta-analysis.
    Li N; Gou ZP; Du SQ; Zhu XH; Lin H; Liang XF; Wang YS; Feng P
    Clin Rheumatol; 2022 Mar; 41(3):677-688. PubMed ID: 34993729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.